medigraphic.com
Colegio de Medicina Interna de México.

2018, Number 2

<< Back Next >>

Med Int Mex 2018; 34 (2)

Value of C-reactive protein (CRP)/ albumin index in the diagnosis of sepsis

Arellano-Navarro CE, Huerta-Ramírez S, Elizalde-Barrera CI, Rubio-Guerra AF, Garro-Almendaro Ak, González-Moreno FJ

Language: Spanish
References: 18
Page: 188-195
PDF size: 462.18 Kb.


ABSTRACT

Background: Sepsis is one of the main causes of morbidity and mortality worldwide, in this entity the impact of the inflammatory response can worsen the patient’s prognosis.
Objective: To find out if there is a correlation between the C-reactive protein (CRP)/albumin index and SOFA and qSOFA scores that allow us to establish its utility as a diagnostic tool.
Material and Method: A cross-sectional analytical study carried out from July 2016 to June 2017 at the Emergency Department of the General Hospital Xoco, SEDESA. We included patients who were diagnosed with sepsis using SOFA and qSOFA scales in whom the CRP/albumin index was determined. We then proceeded to search for correlation between these measurements.
Results: There were included 30 patients. There was no correlation between qSOFA (p = 0.79) and SOFA (p = 0.40) scores with the CRP/ albumin index. This index was lower in females (p = 0.03). We found a statistically significant relationship of hospital death with a lower CRP/albumin index (p = 0.05). Other variables that correlated with death were age (p = 0.01) and SOFA (p = 0.02).
Conclusions: There is no significant correlation between CRP/ albumin index and qSOFA and SOFA score in the diagnosis of sepsis. A lower CRP/albumin index was found in female patients and who died in hospital. Other variables that correlated with death were age and SOFA score.


REFERENCES

  1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369(9):840-851. [PubMed: 23984731].

  2. Ranzani OT, Zampieri FG. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PloS One March 2013;8(3):e59321.

  3. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Shock Septic (Sepsis-3). JAMA 2016 February 23;315(8):801-810.

  4. Cárdenas TM, Ensor J, Wakefield C, et al. Cross-validation of a sequential organ failure assessment score–based model to predict mortality in patients with cancer admitted to the intensive care unit. J Crit Care 2012;27:673-680.

  5. Kim HJ, Jin YA, Je ES. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLOS ONE | DOI:10.1371/journal.pone.0132109.

  6. Hillas G, Vassilakopoulos T. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilatorassociated pneumonia. Eur Respir J 2010;35:805-811.

  7. Al-Subaie N, Reynolds T, Myers A, Sunderland R, et al. Creactive protein as a predictor of outcome after discharge from the intensive care: a prospective observational study. Br J Anaesth 2010;105(3):318-25.

  8. Sun JK, Sun F, Wang X, Yuan ST, Zheng SY, Mu XW. Risk factors and prognosis of hypoalbuminemia in surgical septic patients. Risk factors and prognosis of hypoalbuminemia in surgical septic patients. PeerJ 3:e1267; DOI 10.7717/peerj.1267.

  9. Bhattacharya B, Prashant A, Vishwanath P, Suma MN, Nataraj B. Prediction of outcome and prognosis of patients on mechanical ventilation using body mass index, SOFA score, C-reactive protein, and serum albumin. Indian J Crit Care Med 2011 Apr-Jun;15(2):82-87. doi: 10.4103/0972- 5229.83011.

  10. Takahashi R, Ito Y, Takahashi H, Ishii H, et al. Combined values of serum albumin, C-reactive protein and body mass index at dialysis initiation accurately predicts longterm mortality. Am J Nephrol 2012;36:136-143. DOI: 10.1159/000339940.

  11. Zhou T, Zhan J, Hong S, Hu Z, et al. Ratio of C-reactive protein/ albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Nature. Scientific Reports 5:10481. DOI: 10.1038/ srep10481.

  12. Kinoshita A, Onoda H, Imai N, Iwaku A, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol 2015;22:803-810. DOI 10.1245/s10434-014-4048-0.

  13. Lee P, Wu X. Review: modifications of human serum albumin and their binding effect. Curr Pharm Des 2015;21(14):1862-1865.

  14. Pepys M, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812. doi:10.1172/ JCI200318921.

  15. Guillén JA, Hawkins M, Mislov BE. Reactantes de fase aguda y su impacto en el estado nutricional. Rev Med Cient 2001;14(1):12-18.

  16. Ritchie RF, Palomaki GE, Neveux LM. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin, and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999;13(6):273-9. DOI:10.1002/(SICI)1098-2825.

  17. Ananian P, Hardwigsen J, Bernard D, Le Treut YP. Serum acute- phase protein level as indicator for liver failure after liver resection. Hepatogastroenterology 2005;52(63):857-61.

  18. Cardoso CR, Leite NC, Salles GF. Prognostic importance of C-reactive protein in high cardiovascular risk patients with type 2 diabetes mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study. J Am Heart Assoc 2016 Oct 26;5(11). pii: e004554.




2020     |     www.medigraphic.com